Survival Rate of Liver Transplantation in Asia: A Systematic Review and Meta-Analysis
-
Mousa Ghelichi-Ghojogh
,
Abdolhalim Rajabi
,
Fateme Mohammadizadeh
,
Layla Shojaie
,
Mouhebat Vali
,
Sima Afrashteh
,
Soheil Hassanipour
,
Hossein-Ali Nikbakht
,
Rozhan Khezri
,
Ehsan Allah kalteh
,
Mohammad Fararouei
Abstract
Background: Liver transplantation is one of the most effective treatments for acute liver failure, chronic liver cirrhosis, and hepatocellular carcinoma. This study was implemented to evaluate the survival rate of liver transplant in Asia.
Methods: Studies that investigated the survival rate of liver transplant were selected using a systematic search strategy in the following databases: Medline, Embase, Scopus, ProQuest, ISI Web of Science, and Cochrane to November 30th, 2020. The extracted data were entered into the Excel software. Then, stata 16.0 was used for analysis. The search identified 3046 articles of which, 713 were duplicates and 2156 deemed as irrelevant after reading titles and abstracts. Also, 51 articles were excluded as they were not original (i.e. letter, commentary, review) or did not meet the inclusion criteria. As such, 117 studies, involving 406,646 participants, were included in this meta-analysis.
Results: In this study one, 2, 3, 5, and 10-year survival rates of liver transplant were estimated to be 85%, 80%, 75%, 73%, and 71%, respectively.
Conclusion: This study suggests that the survival rate of liver transplant in Asia is comparable with the corresponding rate reported in the United States and Europe. This study provides a better and more clear view of the efficiency of medical cares, regarding liver transplantation.
1. Madreseh E, Mahmoudi M, Nassiri-Toosi M, et al (2020). Post Liver Transplantation Survival and Related Prognostic Factors among Adult Recipients in Tehran Liver Transplant Center; 2002–2019. Arch Iran Med, 23(5):326-34.
2. Ghelichi-Ghojogh M, Javanian M, Amiri S, et al (2022). The survival rate of liver transplantation in children: a systematic review and meta-analysis. Pediatr Surg Int, 38(9):1177-1186.
3. Burra P, Burroughs A, Graziadei I, et al (2016). EASL clinical practice guidelines: liver transplantation. J Hepatol, 64(2):433-85.
4. Wahid NA, Rosenblatt R, Brown Jr RS (2021). A review of the current state of liver transplantation disparities. Liver Transpl, 27(3):434-43.
5. Yang LS, Shan LL, Saxena A, et al (2014). Liver transplantation: a systematic review of long‐term quality of life. Liver Int, 34(9):1298-313.
6. Kemmer NM, Neff GWJT (2009). Liver transplantation trends and survival in the Asian population. Transplantation, 88(3):392-4.
7. Müller PC, Kabacam G, Vibert E, et al (2020). Current status of liver transplantation in Europe. Int J Surg, 82S:22-9.
8. Germani G, Zeni N, Zanetto A, et al (2020). Influence of donor and recipient gender on liver transplantation outcomes in Europe. Liver Int, 40(8):1961-71.
9. Cotter TG, Minhem M, Wang J, et al (2021). Living‐Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes and Factors Associated with Outcomes. Liver Transpl, 27(7):1019-1031.
10. Åberg F, Gissler M, Karlsen TH, et al (2015). Differences in long‐term survival among liver transplant recipients and the general population: a population‐based Nordic study. Hepatology, 61(2):668-77.
11. Kaido T (2020). Recent evolution of living donor liver transplantation at Kyoto University: How to achieve a one-year overall survival rate of 99%? Hepatobiliary Pancreat Dis Int, 19(4):328-33.
12. Moher D, Liberati A, Tetzlaff J, Altman DG (2010). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg, 8(5):336-41.
13. Hoy D, Brooks P, Woolf A, et al (2012). Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol, 5(9):934-9.
14. Thompson SG, Higgins JPJSim (2002). How should meta‐regression analyses be undertaken and interpreted? Stat Med, 21(11):1559-73.
15. Mavridis D, Salanti G (2014). How to assess publication bias: funnel plot, trim-and-fill method and selection models. Evid Based Ment Health, 17(1):30.
16. Hirata M, Sugawara Y, Makuuchi M (2002). Living-donor liver transplantation at Tokyo University. Clin Transpl, 215-9.
17. Ikegami T, Kawasaki S (2002). Liver transplantation for fulminant hepatitis. Nihon Geka Gakkai Zasshi, 103(5):401-7.
18. Wei W, Tsoi N, Ng I, et al (2002). Ten-year experience with liver transplantation at Queen Mary Hospital: retrospective study. Hong Kong Med J, 8(4):240-4.
19. Zheng S-S, Liang T-B, Wang W-L, et al (2002). Clinical experience in liver transplantation from an organ transplantation center in China. Hepatobiliary Pancreat Dis Int, 1(4):487-91.
20. Sugawara Y, Makuuchi M, Kaneko J, et al (2003). Living‐donor liver transplantation in adults: Tokyo University experience. J Hepatobiliary Pancreat Surg,10(1):1-4.
21. Wong A, Lo C, Liu C (2003). Outcome for Hong Kong residents undergoing cadaveric liver transplantation in mainland China. Hong Kong Med J, 9(3):165-70.
22. Hashikura Y, Kawasaki S (2004). Living donor liver transplantation: issues regarding left liver grafts. HPB (Oxford), 6(2):99-105.
23. Hasegawa K, Sugawara Y, Imamura H, et al (2005). Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center. Transpl Int, 18(7):794-9.
24. Malek-Hosseini S, Mehdizadeh A, Salahi H, et al (2005). Results of liver transplantation: analysis of 140 cases at a single center. Transplant Proc, 37(7):3157-8.
25. Yong C-C, Chen Y-S, Wang et al (2005). Deceased-donor liver transplantation: 10 years’ experience at Change Gung Memorial Hospital-Kaohsiung Medical Center. Chang Gung Med J, 28(3):133-41.
26. Zhou J, Fan J, Wu Z-q, et al (2005). Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China. Chin Med J (Engl), 118(08):654-9.
27. Bharat A, Brown DB, Crippin JS, et al (2006). Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg, 203(4):411-20.
28. Fan J, Zhou J, Xu Y, et al (2006). Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria. Zhonghua Yi Xue Za Zhi, 86(18):1227-31.
29. Wai C, Lee Y, Selamat D, et al (2006). Liver transplantation in Singapore. Singapore Med J, 47(7):580-3.
30. Wang X-h, Yan L-n, Zhang F, et al (2006). Early experiences on living donor liver transplantation in China: multicenter report. Chin Med J (Engl), 119(12):1003-9.
31. Yokoi H, Isaji S, Yamagiwa K, et al (2006). The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg, 13(2):123-30.
32. Huang J (2007). Ethical and legislative perspectives on liver transplantation in the People's Republic of China. Liver Transpl, 13(2):193-6.
33. Morioka D, Egawa H, Kasahara M, et al (2007). Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases. Ann Surg, 245(2):315-25.
34. Rakela J, Fung JJ (2007). Liver transplantation in China. Liver Transpl, 13(2):182.
35. Concejero A, Chen C-L, Wang C-C, et al (2008). Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan. Transplantation, 85(3):398-406.
36. Eguchi S, Takatsuki M, Hidaka M, et al (2008). Evolution of living donor liver transplantation over 10 years: experience of a single center. Surg Today, 38(9):795-800.
37. Ikegami T, Taketomi A, Soejima Y, et al (2008). Living donor liver transplantation for acute liver failure: a 10-year experience in a single center. J Am Coll Surg, 206(3):412-8.
38. Lin N-C, Hsia C-Y, Loong C-C, et al (2008). Liver transplantation at a small-volume procedure center—preliminary results from Taipei Veterans General Hospital. J Chin Med Assoc, 71(4):186-90.
39. Pandey D, Wai CT, Lee KH, Tan KC (2008). Living donor liver transplantation for hepatocellular carcinoma: a single centre experience. Indian J Gastroenterol, 27:148-52.
40. Shen Z-y, Wang Z-f, Zhu Z-j, et al (2008). Pediatric liver transplantation in 31 consecutive children. Chin Med J (Engl), 121(20):2001-3.
41. Chan KL, Fan ST, Lo CM, et al (2009). Pediatric liver transplantation in Hong Kong-a domain with scarce deceased donors. J Pediatr Surg, 44(12):2316-21.
42. Chen GH (2009). Liver transplantation in China: retrospect and prospect. Chin Med J (Engl), 122(19):2229-30.
43. Cheng F, Li GQ, Zhang F, et al (2009). Outcomes of living-related liver transplantation for Wilson's disease: a single-center experience in China. Transplantation, 87(5):751-7.
44. García-Valdecasas JC, Fuster J, Fondevila C, Calatayud D (2009). Adult living-donor liver transplantation. Gastroenterol Hepatol, 32(8):577-83.
45. Fan ST, Wang H, Lam BK (2009). Follow-up of Chinese liver transplant recipients in Hong Kong. Liver Transpl, 15(5):544-50.
46. Kuo WT, Hsia CY, Loong CC, et al (2009). Outcome of foreign residents undergoing deceased donor liver transplantation in China: a single-center experience in Taiwan. Liver Transpl, 15(11):1579-85.
47. Li J, Yan LN, Yang J, et al (2009). Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol, 15(33):4170-6.
48. Sabet B, Rajaee-fard A, Nikeghbalian S, Malek-Hosseini SA (2009). Six years liver transplants outcome in Shiraz transplant center. J Isfahan Med School, 27(99):543-50.
49. Xiao L, Fu ZR, Ding GS, et al (2009). Liver transplantation for hepatitis B virus-related hepatocellular carcinoma: one center's experience in China. Transplant Proc, 41(5):1717-21.
50. Xiao L, Fu ZR, Ding GS, et al (2009). Prediction of survival after liver transplantation for chronic severe hepatitis B based on preoperative prognostic scores: a single center's experience in China. World J Surg, 33(11):2420-6.
51. Yoshitoshi EY, Takada Y, Oike F, et al (2009). Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation. Transplantation, 87(2):261-7.
52. Allam N, Al Saghier M, El Sheikh Y, et al (2010). Clinical outcomes for Saudi and Egyptian patients receiving deceased donor liver transplantation in China. Am J Transplant, 10(8):1834-41.
53. Chen CL, Concejero AM (2010). Liver transplantation for hepatocellular carcinoma in the world: the Taiwan experience. J Hepatobiliary Pancreat Sci, 17(5):555-8.
54. Mohamed El Moghazy W, Ogura Y, Mutsuko M, et al (2010). Pediatric living-donor liver transplantation for acute liver failure: analysis of 57 cases. Transpl Int, 23(8):823-30.
55. Faraj W, Deborah Mukherji D, Fakih H, et al (2010). Liver transplantation in Lebanon: A hard lesson to learn. Ann Transplant, 15(3):25-9.
56. Ikegami T, Soejima Y, Shirabe K, et al (2010). Evolving strategies to prevent biliary strictures after living donor liver transplantation. Transplant Proc, 42(9):3624-9.
57. Zhu M, Li Y, Xia Q, et al (2010). Strong impact of acute kidney injury on survival after liver transplantation. Transplant Proc, 42(9):3634-8.
58. Gwon DI, Sung KB, Ko GY, et al (2011). Dual catheter placement technique for treatment of biliary anastomotic strictures after liver transplantation. Liver Transpl, 17(2):159-66.
59. Hu X-X, Yan L-N (2011). Retrospective analysis of prognostic factors after liver transplantation for intrahepatic cholangiocarcinoma in China: a single-center experience. Hepatogastroenterology, 58(109):1255-9.
60. Hu Z, Zhou J, Xu X, et al (2012). Salvage liver transplantation is a reasonable option for selected patients who have recurrent hepatocellular carcinoma after liver resection. PLoS One, 7(5):e36587.
61. Kim J, Kwon C, Joh J-W, et al (2012). Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria. Transplant Proc, 44(2):403-8.
62. Lee H-J, Hwang S, Ahn C-S, et al (2012). Long-term outcomes of portal Y-graft interposition for anomalous right portal veins in living donor liver transplantation. Transplant Proc, 44(2):454-6.
63. Mizuta K, Urahashi T, Ihara Y, et al (2012). Living donor liver transplantation in children with cholestatic liver disease: a single-center experience. Transplant Proc, 44(2):469-72.
64. Oh S, Kim K, Kim D, et al (2012). Clinical experience of more than 200 cases of pediatric liver transplantation at a single center: improved patient survival. Transplant Proc, 44(2):484-6.
65. Poon K-S, Chen T-H, Jeng L-B, et al (2012). A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation. Transplant Proc, 44(2):316-9.
66. Wai C-T, Woon W-A, Tan Y-M, et al (2012). Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation. Transplant Proc, 44(2):516-9.
67. Wai C-T, Woon W-A, Tan Y-M, et al (2012). Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation. Transplant Proc, 44(2):396-8.
68. Xu L, Xu M-Q, Yan L-N, et al (2012). Causes of mortality after liver transplantation: a single center experience in mainland china. Hepatogastroenterology, 59(114):481-4.
69. Yoshizumi T, Shirabe K, Ikegami T, et al (2012). Impact of human T cell leukemia virus type 1 in living donor liver transplantation. Am J Transplant, 12(6):1479-85.
70. Yu C-Y, Ou H-Y, Huang T-L, et al (2012). Hepatocellular carcinoma downstaging in liver transplantation. Transplant Proc, 44(2):412-4.
71. Haseli N, Hassanzade J, Dehghani SM, et al (2013). Living related donor liver transplantation in Iranian children: a 12-year experience. Gastroenterol Hepatol Bed Bench, 6(4):183-9.
72. Haseli N, Hassanzadeh J, Dehghani SM, et al (2013). Long-term survival and its related factors in pediatric liver transplant recipients of shiraz transplant center, shiraz, iran in 2012. Hepat Mon, 13(7) :e10257.
73. Hu Z, Zhou J, Wang H, et al (2013). Survival in liver transplant recipients with hepatitis B-or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010. PLoS One, 8(4):e61620.
74. Jiang L, Yan L-N, Wen T-F, et al (2013). Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria. Hepatobiliary Pancreat Dis Int, 12(5):494-9.
75. Kasahara M, Umeshita K, Inomata Y, et al (2013). Long‐term outcomes of pediatric living donor liver transplantation in Japan: an analysis of more than 2200 cases listed in the registry of the Japanese Liver Transplantation Society. Am J Transplant, 13(7):1830-9.
76. Kim JM, Kim KM, Yi N-J, et al (2013). Pediatric liver transplantation outcomes in Korea. J Korean Med Sci, 28(1):42-7.
77. Pillai VG, Chen C-L (2016). Living donor liver transplantation in Taiwan—challenges beyond surgery. Hepatobiliary Surg Nutr, 5(2):145-50.
78. Lei J, Yan L (2013). Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies. J Gastrointest Surg, 17(6):1116-22.
79. Lei J-Y, Wang W-T, Yan L-N (2013). Up-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysis. World J Gastroenterol, 19(36):6077-83.
80. Li C-T, Luo J, Zhang Z-W (2013). Risk factors for massive ascites after living donor liver transplantation in adult and impact of massive ascites on patient survival. Sichuan Da Xue Xue Bao Yi Xue Ban, 44(4):632-6.
81. Sun L-Y, Yang Y-S, Zhu Z-J, et al (2013). Outcomes in children with biliary atresia following liver transplantation. Hepatobiliary Pancreat Dis Int, 12(2):143-8.
82. Takada Y, Uemoto S (2013). Living donor liver transplantation for hepatitis C. Surg Today, 43(7):709-14.
83. Yoshizumi T, Ikegami T, Yoshiya S, et al (2013). Impact of tumor size, number of tumors and neutrophil‐to‐lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma. Hepatol Res, 43(7):709-16.
84. Al Sebayel MI, Abaalkhail FA, Al Bahili H, et al (2014). Liver transplantation at KFSHRC: Achievement and challenges. Ann Saudi Med, 34(2):103-6.
85. Kabiling CS, Chen C-L, Concejero A, et al (2014). Section 18. Professional framework for liver transplantation for overseas patients: traveling for living donor liver transplantation. Transplantation, 97 Suppl 8:S75-9.
86. Kumaran V (2014). Role of liver transplantation for hepatocellular carcinoma. J Clin Exp Hepatol, 4(Suppl 3):S97-S103.
87. Lei JY, Wang WT, Yan LN (2014). Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience. Eur J Gastroenterol Hepatol, 26(2):200-4.
88. Liang B-y, Huang Z-y, Zhou S-j, et al (2014). Primary results of salvage liver transplantation in the patients with unresectable recurrent hepatocellular carcinoma after initial liver resection. Hepatogastroenterology, 61(135):2014-20.
89. Wang P, Wang C, Li H, et al (2015). Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience. Onco Targets Ther, 8:3775-81.
90. Oh SH, Kim KM, Kim DY, et al (2014). Improved outcomes in liver transplantation in children with acute liver failure. J Pediatr Gastroenterol Nutr, 58(1):68-73.
91. Yabuta M, Shibata T, Shibata T, et al (2014). Long-term outcome of percutaneous transhepatic balloon angioplasty for portal vein stenosis after pediatric living donor liver transplantation: a single institute’s experience. J Vasc Interv Radiol, 25(9):1406-12.
92. Al Sebayel M, Abaalkhail F, Hashim A, et al (2015). Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score. Transplant Proc, 47(4):1211-3.
93. Faraj W, Haydar A, Nounou GE, et al (2015). Update on liver transplants in Lebanon. Prog Transplant, 25(3):271-5.
94. Sakamoto S, Kasahara M, Ogura Y, et al (2015). Current status of deceased donor split liver transplantation in Japan. J Hepatobiliary Pancreat Sci, 22(12):837-45.
95. Dong J, Zhu Y, Ma F, et al (2016). Conditional disease-free survival after liver transplantation for hepatocellular carcinoma: a two-center experience. Medicine (Baltimore), 95(31):e4383.
96. Eguchi S, Furukawa H, Uemoto S, et al (2016). Outcomes of living donor liver transplantation alone for patients on maintenance renal replacement therapy in Japan: results of a Nationwide Survey. Transplant Direct, 2(6):e74.
97. Sugawara Y, Yamamoto H, Hibi T (2018). Living donor liver transplantation for patients with hepatocellular carcinoma in Japan. Hepatoma Res,4:33.
98. Liu X, Wang B, Zhang X, et al (2016). Liver transplantation using donation after brain and cardiac death: a single-center experience in China. Transplant Proc, 48(6):1879-86.
99. Togashi J, Akamastu N, Kokudo N (2016). Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital. Hepatobiliary Surg Nutr,5(5):399-407.
100. Hosseini SAM, Nikeghbalian S, Salahi H, et al (2017). Evolution of liver transplantation program in Shiraz, Iran. Hepat Mon, 17(11): e60745.
101. Umeshita K, Eguchi S, Egawa H, et al (2019). Liver transplantation in Japan: registry by the Japanese liver transplantation society. Hepatol Res, 49(9):964-80.
102. Ushigome H, Nakao T, Harada S, et al (2016). Elderly living donor liver transplant recipients over 60 Years old at a japanese single center. Transplant Proc, 48(4):1115-8.
103. Wang T-J, Lin C-H, Chang S-N, et al (2016). Long-term outcome of liver transplant recipients after the development of renal failure requiring dialysis: a study using the National Health Insurance Database in Taiwan. Transplant Proc, 48(4):1194-7.
104. Yoshizumi T, Takada Y, Shirabe K, et al (2016). Impact of human T‐cell leukemia virus type 1 on living donor liver transplantation: a multi‐center study in Japan. J Hepatobiliary Pancreat Sci, 23(6):333-41.
105. Zhang Q, Deng Y-L, Liu C, et al (2016). Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol, 22(43):9571-85.
106. Kositamongkol P, Sanphasitvong V, Sirivatanauksorn Y, et al (2017). Outcome of liver transplantation in hepatocellular carcinoma patients at Siriraj Hospital. Transplant Proc, 49(5):1114-1117.
107. Wei Q, Nemdharry RS, Zhuang R-Z, et al (2017). A good prognostic predictor for liver transplantation recipients with benign end-stage liver cirrhosis. Hepatobiliary Pancreat Dis Int, 16(2):164-8.
108. Wei L, Chen D, Zhang B, et al (2018). Long‐term outcome and recurrence of hepatitis B virus following liver transplantation from hepatitis B surface antigen‐positive donors in a Chinese population. J Viral Hepat, 25(12):1576-81.
109. Hsu C-T, Chang M-H, Ho M-C, et al (2019). Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan. J Formos Med Assoc, 118(11):1537-45.
110. Zakaria HM, Sallam AN, Ayoub II, et al (2017). Predictors of outcome of living donor liver transplantation for hepatocellular carcinoma. Indian J Surg, 79(4):299-307.
111. Morise Z (2019). Developments and perspectives of laparoscopic liver resection in the treatment of hepatocellular carcinoma. Surg Today,49(8):649-55.
112. Miura K, Sakamoto S, Shimata K, et al (2017). The outcomes of pediatric liver retransplantation from a living donor: a 17-year single-center experience. Surg Today, 47(11):1405-14.
113. Zongyi Y, Baifeng L, Funian Z, et al (2017). Risk factors of acute kidney injury after orthotopic liver transplantation in China. Sci Rep, 7:41555.
114. Kamo N, Kaido T, Yagi S, et al (2018). Liver transplantation for intermediate-stage hepatocellular carcinoma. Liver Cancer, 7(2):179-89.
115. Kasahara M, Umeshita K, Sakamoto S, et al (2018). Living donor liver transplantation for biliary atresia: an analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society. Am J Transplant, 18(3):659-68.
116. Lee EC, Kim SH, Shim JR, Park SJ (2018). Small‐for‐size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria. Liver Transpl, 24(1):35-43.
117. Lei M, Yan L-N, Yang J-Y, et al (2018). Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China. World J Gastroenterol, 24(48):5525-5536.
118. Malek-Hosseini SA, Jafarian A, Nikeghbalian S, et al (2018). Liver transplantation status in Iran: a multi-center report on the main transplant indicators and survival rates. Arch Iran Med, 21(7):275-82.
119. Zhong C-P, Xi Z-F, Xia Q (2018). Clinical analysis of liver transplantation in autoimmune liver diseases. Hepatobiliary Pancreat Dis Int, 17(1):27-31.
120. Chen W, Yadav DK, Bai X, et al (2019). Liver transplantation from voluntary organ donor system in China: a comparison between DBD and DCD liver transplants. Gastroenterol Res Pract, 2019:5736702.
121. Baimakhanov Z, Kaniev S, Doskhanov M, et al (2019). Evolution of Liver Transplantation in Kazakhstan: Two-Era Experience of a Single Center, the First Report. Transplant Proc, 51(10):3360-3363.
122. Shen Z, Gu C, Zheng H, et al (2019). A twenty-year review of clinical liver transplantation. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 31(3):269-80.
123. Kurata N, Ogura Y, Ogiso S, et al (2019). Splenectomy in living donor liver transplantation and risk factors of portal vein thrombosis. Hepatobiliary Pancreat Dis Int, 18(4):337-42.
124. Madreseh E, Mahmoudi M, Nassiri-Toosi M, et al (2020). Post Liver Transplantation Survival and Related Prognostic Factors among Adult Recipients in Tehran Liver Transplant Center; 2002–2019. Arch Iran Med, 23(5):326-334.
125. Basiratnia M, Dehghani SM, Razmjoee F, Derakhshan D (2020). Prevalence of Renal Dysfunction Among Pediatric Liver Transplant Recipients. Iran J Kidney Dis, 14(2):119-125.
126. Malek-Hosseini SA, Habibzadeh F, Nikeghbalian S (2019). Shiraz organ transplant center: the largest liver transplant center in the world. Transplantation, 103(8):1523-5.
127. Nikeghbalian S, Malekhosseini SA, Kazemi K, et al (2021). The largest single center report on pediatric liver transplantation: experiences and lessons learned. Ann Surg, 273(2):e70-e72.
128. Roberts MS, Angus DC, Bryce CL, et al (2004). Survival after liver transplantation in the United States: a disease‐specific analysis of the UNOS database. Liver Transpl, 10(7):886-97.
129. Dueland S, Syversveen T, Solheim JM, et al (2020). Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases. Ann Surg, 271(2):212-8.
130. Vogt DP, Henderson JM, Carey WD, Barnes DJS (2002). The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery, 132(4):775-80.
131. Cuervas‐Mons V, Martinez AJ, Dekker A, et al (1986). Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology, 6(3):495-501.
132. Mora NP, Klintmalm GB, Solomon H, et al (1992). Survival after liver transplantation in 300 consecutive patients: the influence of age, clinical status, and pretransplant disease. Transplant Proc, 24(1):156-7.
133. Jain A, Reyes J, Kashyap R, et al (2000). Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg, 232(4):490-500.
134. Smits J, De Meester J, Persijn G, et al (1996). Long-term results of solid organ transplantation. Report from the Eurotransplant International Foundation. Clin Transpl, 109-27.
135. Saidi RF (2012). Current status of liver transplantation. Arch Iran Med, 15(12):772-6.
136. Kadohisa M, Inomata Y, Uto K, et al (2021). Impact of Donor Age on the Outcome of Living-donor Liver Transplantation: Special Consideration to the Feasibility of Using Elderly Donors. Transplantation, 105(2):328-37.
2. Ghelichi-Ghojogh M, Javanian M, Amiri S, et al (2022). The survival rate of liver transplantation in children: a systematic review and meta-analysis. Pediatr Surg Int, 38(9):1177-1186.
3. Burra P, Burroughs A, Graziadei I, et al (2016). EASL clinical practice guidelines: liver transplantation. J Hepatol, 64(2):433-85.
4. Wahid NA, Rosenblatt R, Brown Jr RS (2021). A review of the current state of liver transplantation disparities. Liver Transpl, 27(3):434-43.
5. Yang LS, Shan LL, Saxena A, et al (2014). Liver transplantation: a systematic review of long‐term quality of life. Liver Int, 34(9):1298-313.
6. Kemmer NM, Neff GWJT (2009). Liver transplantation trends and survival in the Asian population. Transplantation, 88(3):392-4.
7. Müller PC, Kabacam G, Vibert E, et al (2020). Current status of liver transplantation in Europe. Int J Surg, 82S:22-9.
8. Germani G, Zeni N, Zanetto A, et al (2020). Influence of donor and recipient gender on liver transplantation outcomes in Europe. Liver Int, 40(8):1961-71.
9. Cotter TG, Minhem M, Wang J, et al (2021). Living‐Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes and Factors Associated with Outcomes. Liver Transpl, 27(7):1019-1031.
10. Åberg F, Gissler M, Karlsen TH, et al (2015). Differences in long‐term survival among liver transplant recipients and the general population: a population‐based Nordic study. Hepatology, 61(2):668-77.
11. Kaido T (2020). Recent evolution of living donor liver transplantation at Kyoto University: How to achieve a one-year overall survival rate of 99%? Hepatobiliary Pancreat Dis Int, 19(4):328-33.
12. Moher D, Liberati A, Tetzlaff J, Altman DG (2010). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg, 8(5):336-41.
13. Hoy D, Brooks P, Woolf A, et al (2012). Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol, 5(9):934-9.
14. Thompson SG, Higgins JPJSim (2002). How should meta‐regression analyses be undertaken and interpreted? Stat Med, 21(11):1559-73.
15. Mavridis D, Salanti G (2014). How to assess publication bias: funnel plot, trim-and-fill method and selection models. Evid Based Ment Health, 17(1):30.
16. Hirata M, Sugawara Y, Makuuchi M (2002). Living-donor liver transplantation at Tokyo University. Clin Transpl, 215-9.
17. Ikegami T, Kawasaki S (2002). Liver transplantation for fulminant hepatitis. Nihon Geka Gakkai Zasshi, 103(5):401-7.
18. Wei W, Tsoi N, Ng I, et al (2002). Ten-year experience with liver transplantation at Queen Mary Hospital: retrospective study. Hong Kong Med J, 8(4):240-4.
19. Zheng S-S, Liang T-B, Wang W-L, et al (2002). Clinical experience in liver transplantation from an organ transplantation center in China. Hepatobiliary Pancreat Dis Int, 1(4):487-91.
20. Sugawara Y, Makuuchi M, Kaneko J, et al (2003). Living‐donor liver transplantation in adults: Tokyo University experience. J Hepatobiliary Pancreat Surg,10(1):1-4.
21. Wong A, Lo C, Liu C (2003). Outcome for Hong Kong residents undergoing cadaveric liver transplantation in mainland China. Hong Kong Med J, 9(3):165-70.
22. Hashikura Y, Kawasaki S (2004). Living donor liver transplantation: issues regarding left liver grafts. HPB (Oxford), 6(2):99-105.
23. Hasegawa K, Sugawara Y, Imamura H, et al (2005). Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center. Transpl Int, 18(7):794-9.
24. Malek-Hosseini S, Mehdizadeh A, Salahi H, et al (2005). Results of liver transplantation: analysis of 140 cases at a single center. Transplant Proc, 37(7):3157-8.
25. Yong C-C, Chen Y-S, Wang et al (2005). Deceased-donor liver transplantation: 10 years’ experience at Change Gung Memorial Hospital-Kaohsiung Medical Center. Chang Gung Med J, 28(3):133-41.
26. Zhou J, Fan J, Wu Z-q, et al (2005). Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China. Chin Med J (Engl), 118(08):654-9.
27. Bharat A, Brown DB, Crippin JS, et al (2006). Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg, 203(4):411-20.
28. Fan J, Zhou J, Xu Y, et al (2006). Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria. Zhonghua Yi Xue Za Zhi, 86(18):1227-31.
29. Wai C, Lee Y, Selamat D, et al (2006). Liver transplantation in Singapore. Singapore Med J, 47(7):580-3.
30. Wang X-h, Yan L-n, Zhang F, et al (2006). Early experiences on living donor liver transplantation in China: multicenter report. Chin Med J (Engl), 119(12):1003-9.
31. Yokoi H, Isaji S, Yamagiwa K, et al (2006). The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg, 13(2):123-30.
32. Huang J (2007). Ethical and legislative perspectives on liver transplantation in the People's Republic of China. Liver Transpl, 13(2):193-6.
33. Morioka D, Egawa H, Kasahara M, et al (2007). Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases. Ann Surg, 245(2):315-25.
34. Rakela J, Fung JJ (2007). Liver transplantation in China. Liver Transpl, 13(2):182.
35. Concejero A, Chen C-L, Wang C-C, et al (2008). Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan. Transplantation, 85(3):398-406.
36. Eguchi S, Takatsuki M, Hidaka M, et al (2008). Evolution of living donor liver transplantation over 10 years: experience of a single center. Surg Today, 38(9):795-800.
37. Ikegami T, Taketomi A, Soejima Y, et al (2008). Living donor liver transplantation for acute liver failure: a 10-year experience in a single center. J Am Coll Surg, 206(3):412-8.
38. Lin N-C, Hsia C-Y, Loong C-C, et al (2008). Liver transplantation at a small-volume procedure center—preliminary results from Taipei Veterans General Hospital. J Chin Med Assoc, 71(4):186-90.
39. Pandey D, Wai CT, Lee KH, Tan KC (2008). Living donor liver transplantation for hepatocellular carcinoma: a single centre experience. Indian J Gastroenterol, 27:148-52.
40. Shen Z-y, Wang Z-f, Zhu Z-j, et al (2008). Pediatric liver transplantation in 31 consecutive children. Chin Med J (Engl), 121(20):2001-3.
41. Chan KL, Fan ST, Lo CM, et al (2009). Pediatric liver transplantation in Hong Kong-a domain with scarce deceased donors. J Pediatr Surg, 44(12):2316-21.
42. Chen GH (2009). Liver transplantation in China: retrospect and prospect. Chin Med J (Engl), 122(19):2229-30.
43. Cheng F, Li GQ, Zhang F, et al (2009). Outcomes of living-related liver transplantation for Wilson's disease: a single-center experience in China. Transplantation, 87(5):751-7.
44. García-Valdecasas JC, Fuster J, Fondevila C, Calatayud D (2009). Adult living-donor liver transplantation. Gastroenterol Hepatol, 32(8):577-83.
45. Fan ST, Wang H, Lam BK (2009). Follow-up of Chinese liver transplant recipients in Hong Kong. Liver Transpl, 15(5):544-50.
46. Kuo WT, Hsia CY, Loong CC, et al (2009). Outcome of foreign residents undergoing deceased donor liver transplantation in China: a single-center experience in Taiwan. Liver Transpl, 15(11):1579-85.
47. Li J, Yan LN, Yang J, et al (2009). Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol, 15(33):4170-6.
48. Sabet B, Rajaee-fard A, Nikeghbalian S, Malek-Hosseini SA (2009). Six years liver transplants outcome in Shiraz transplant center. J Isfahan Med School, 27(99):543-50.
49. Xiao L, Fu ZR, Ding GS, et al (2009). Liver transplantation for hepatitis B virus-related hepatocellular carcinoma: one center's experience in China. Transplant Proc, 41(5):1717-21.
50. Xiao L, Fu ZR, Ding GS, et al (2009). Prediction of survival after liver transplantation for chronic severe hepatitis B based on preoperative prognostic scores: a single center's experience in China. World J Surg, 33(11):2420-6.
51. Yoshitoshi EY, Takada Y, Oike F, et al (2009). Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation. Transplantation, 87(2):261-7.
52. Allam N, Al Saghier M, El Sheikh Y, et al (2010). Clinical outcomes for Saudi and Egyptian patients receiving deceased donor liver transplantation in China. Am J Transplant, 10(8):1834-41.
53. Chen CL, Concejero AM (2010). Liver transplantation for hepatocellular carcinoma in the world: the Taiwan experience. J Hepatobiliary Pancreat Sci, 17(5):555-8.
54. Mohamed El Moghazy W, Ogura Y, Mutsuko M, et al (2010). Pediatric living-donor liver transplantation for acute liver failure: analysis of 57 cases. Transpl Int, 23(8):823-30.
55. Faraj W, Deborah Mukherji D, Fakih H, et al (2010). Liver transplantation in Lebanon: A hard lesson to learn. Ann Transplant, 15(3):25-9.
56. Ikegami T, Soejima Y, Shirabe K, et al (2010). Evolving strategies to prevent biliary strictures after living donor liver transplantation. Transplant Proc, 42(9):3624-9.
57. Zhu M, Li Y, Xia Q, et al (2010). Strong impact of acute kidney injury on survival after liver transplantation. Transplant Proc, 42(9):3634-8.
58. Gwon DI, Sung KB, Ko GY, et al (2011). Dual catheter placement technique for treatment of biliary anastomotic strictures after liver transplantation. Liver Transpl, 17(2):159-66.
59. Hu X-X, Yan L-N (2011). Retrospective analysis of prognostic factors after liver transplantation for intrahepatic cholangiocarcinoma in China: a single-center experience. Hepatogastroenterology, 58(109):1255-9.
60. Hu Z, Zhou J, Xu X, et al (2012). Salvage liver transplantation is a reasonable option for selected patients who have recurrent hepatocellular carcinoma after liver resection. PLoS One, 7(5):e36587.
61. Kim J, Kwon C, Joh J-W, et al (2012). Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria. Transplant Proc, 44(2):403-8.
62. Lee H-J, Hwang S, Ahn C-S, et al (2012). Long-term outcomes of portal Y-graft interposition for anomalous right portal veins in living donor liver transplantation. Transplant Proc, 44(2):454-6.
63. Mizuta K, Urahashi T, Ihara Y, et al (2012). Living donor liver transplantation in children with cholestatic liver disease: a single-center experience. Transplant Proc, 44(2):469-72.
64. Oh S, Kim K, Kim D, et al (2012). Clinical experience of more than 200 cases of pediatric liver transplantation at a single center: improved patient survival. Transplant Proc, 44(2):484-6.
65. Poon K-S, Chen T-H, Jeng L-B, et al (2012). A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation. Transplant Proc, 44(2):316-9.
66. Wai C-T, Woon W-A, Tan Y-M, et al (2012). Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation. Transplant Proc, 44(2):516-9.
67. Wai C-T, Woon W-A, Tan Y-M, et al (2012). Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation. Transplant Proc, 44(2):396-8.
68. Xu L, Xu M-Q, Yan L-N, et al (2012). Causes of mortality after liver transplantation: a single center experience in mainland china. Hepatogastroenterology, 59(114):481-4.
69. Yoshizumi T, Shirabe K, Ikegami T, et al (2012). Impact of human T cell leukemia virus type 1 in living donor liver transplantation. Am J Transplant, 12(6):1479-85.
70. Yu C-Y, Ou H-Y, Huang T-L, et al (2012). Hepatocellular carcinoma downstaging in liver transplantation. Transplant Proc, 44(2):412-4.
71. Haseli N, Hassanzade J, Dehghani SM, et al (2013). Living related donor liver transplantation in Iranian children: a 12-year experience. Gastroenterol Hepatol Bed Bench, 6(4):183-9.
72. Haseli N, Hassanzadeh J, Dehghani SM, et al (2013). Long-term survival and its related factors in pediatric liver transplant recipients of shiraz transplant center, shiraz, iran in 2012. Hepat Mon, 13(7) :e10257.
73. Hu Z, Zhou J, Wang H, et al (2013). Survival in liver transplant recipients with hepatitis B-or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010. PLoS One, 8(4):e61620.
74. Jiang L, Yan L-N, Wen T-F, et al (2013). Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria. Hepatobiliary Pancreat Dis Int, 12(5):494-9.
75. Kasahara M, Umeshita K, Inomata Y, et al (2013). Long‐term outcomes of pediatric living donor liver transplantation in Japan: an analysis of more than 2200 cases listed in the registry of the Japanese Liver Transplantation Society. Am J Transplant, 13(7):1830-9.
76. Kim JM, Kim KM, Yi N-J, et al (2013). Pediatric liver transplantation outcomes in Korea. J Korean Med Sci, 28(1):42-7.
77. Pillai VG, Chen C-L (2016). Living donor liver transplantation in Taiwan—challenges beyond surgery. Hepatobiliary Surg Nutr, 5(2):145-50.
78. Lei J, Yan L (2013). Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies. J Gastrointest Surg, 17(6):1116-22.
79. Lei J-Y, Wang W-T, Yan L-N (2013). Up-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysis. World J Gastroenterol, 19(36):6077-83.
80. Li C-T, Luo J, Zhang Z-W (2013). Risk factors for massive ascites after living donor liver transplantation in adult and impact of massive ascites on patient survival. Sichuan Da Xue Xue Bao Yi Xue Ban, 44(4):632-6.
81. Sun L-Y, Yang Y-S, Zhu Z-J, et al (2013). Outcomes in children with biliary atresia following liver transplantation. Hepatobiliary Pancreat Dis Int, 12(2):143-8.
82. Takada Y, Uemoto S (2013). Living donor liver transplantation for hepatitis C. Surg Today, 43(7):709-14.
83. Yoshizumi T, Ikegami T, Yoshiya S, et al (2013). Impact of tumor size, number of tumors and neutrophil‐to‐lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma. Hepatol Res, 43(7):709-16.
84. Al Sebayel MI, Abaalkhail FA, Al Bahili H, et al (2014). Liver transplantation at KFSHRC: Achievement and challenges. Ann Saudi Med, 34(2):103-6.
85. Kabiling CS, Chen C-L, Concejero A, et al (2014). Section 18. Professional framework for liver transplantation for overseas patients: traveling for living donor liver transplantation. Transplantation, 97 Suppl 8:S75-9.
86. Kumaran V (2014). Role of liver transplantation for hepatocellular carcinoma. J Clin Exp Hepatol, 4(Suppl 3):S97-S103.
87. Lei JY, Wang WT, Yan LN (2014). Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience. Eur J Gastroenterol Hepatol, 26(2):200-4.
88. Liang B-y, Huang Z-y, Zhou S-j, et al (2014). Primary results of salvage liver transplantation in the patients with unresectable recurrent hepatocellular carcinoma after initial liver resection. Hepatogastroenterology, 61(135):2014-20.
89. Wang P, Wang C, Li H, et al (2015). Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience. Onco Targets Ther, 8:3775-81.
90. Oh SH, Kim KM, Kim DY, et al (2014). Improved outcomes in liver transplantation in children with acute liver failure. J Pediatr Gastroenterol Nutr, 58(1):68-73.
91. Yabuta M, Shibata T, Shibata T, et al (2014). Long-term outcome of percutaneous transhepatic balloon angioplasty for portal vein stenosis after pediatric living donor liver transplantation: a single institute’s experience. J Vasc Interv Radiol, 25(9):1406-12.
92. Al Sebayel M, Abaalkhail F, Hashim A, et al (2015). Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score. Transplant Proc, 47(4):1211-3.
93. Faraj W, Haydar A, Nounou GE, et al (2015). Update on liver transplants in Lebanon. Prog Transplant, 25(3):271-5.
94. Sakamoto S, Kasahara M, Ogura Y, et al (2015). Current status of deceased donor split liver transplantation in Japan. J Hepatobiliary Pancreat Sci, 22(12):837-45.
95. Dong J, Zhu Y, Ma F, et al (2016). Conditional disease-free survival after liver transplantation for hepatocellular carcinoma: a two-center experience. Medicine (Baltimore), 95(31):e4383.
96. Eguchi S, Furukawa H, Uemoto S, et al (2016). Outcomes of living donor liver transplantation alone for patients on maintenance renal replacement therapy in Japan: results of a Nationwide Survey. Transplant Direct, 2(6):e74.
97. Sugawara Y, Yamamoto H, Hibi T (2018). Living donor liver transplantation for patients with hepatocellular carcinoma in Japan. Hepatoma Res,4:33.
98. Liu X, Wang B, Zhang X, et al (2016). Liver transplantation using donation after brain and cardiac death: a single-center experience in China. Transplant Proc, 48(6):1879-86.
99. Togashi J, Akamastu N, Kokudo N (2016). Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital. Hepatobiliary Surg Nutr,5(5):399-407.
100. Hosseini SAM, Nikeghbalian S, Salahi H, et al (2017). Evolution of liver transplantation program in Shiraz, Iran. Hepat Mon, 17(11): e60745.
101. Umeshita K, Eguchi S, Egawa H, et al (2019). Liver transplantation in Japan: registry by the Japanese liver transplantation society. Hepatol Res, 49(9):964-80.
102. Ushigome H, Nakao T, Harada S, et al (2016). Elderly living donor liver transplant recipients over 60 Years old at a japanese single center. Transplant Proc, 48(4):1115-8.
103. Wang T-J, Lin C-H, Chang S-N, et al (2016). Long-term outcome of liver transplant recipients after the development of renal failure requiring dialysis: a study using the National Health Insurance Database in Taiwan. Transplant Proc, 48(4):1194-7.
104. Yoshizumi T, Takada Y, Shirabe K, et al (2016). Impact of human T‐cell leukemia virus type 1 on living donor liver transplantation: a multi‐center study in Japan. J Hepatobiliary Pancreat Sci, 23(6):333-41.
105. Zhang Q, Deng Y-L, Liu C, et al (2016). Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol, 22(43):9571-85.
106. Kositamongkol P, Sanphasitvong V, Sirivatanauksorn Y, et al (2017). Outcome of liver transplantation in hepatocellular carcinoma patients at Siriraj Hospital. Transplant Proc, 49(5):1114-1117.
107. Wei Q, Nemdharry RS, Zhuang R-Z, et al (2017). A good prognostic predictor for liver transplantation recipients with benign end-stage liver cirrhosis. Hepatobiliary Pancreat Dis Int, 16(2):164-8.
108. Wei L, Chen D, Zhang B, et al (2018). Long‐term outcome and recurrence of hepatitis B virus following liver transplantation from hepatitis B surface antigen‐positive donors in a Chinese population. J Viral Hepat, 25(12):1576-81.
109. Hsu C-T, Chang M-H, Ho M-C, et al (2019). Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan. J Formos Med Assoc, 118(11):1537-45.
110. Zakaria HM, Sallam AN, Ayoub II, et al (2017). Predictors of outcome of living donor liver transplantation for hepatocellular carcinoma. Indian J Surg, 79(4):299-307.
111. Morise Z (2019). Developments and perspectives of laparoscopic liver resection in the treatment of hepatocellular carcinoma. Surg Today,49(8):649-55.
112. Miura K, Sakamoto S, Shimata K, et al (2017). The outcomes of pediatric liver retransplantation from a living donor: a 17-year single-center experience. Surg Today, 47(11):1405-14.
113. Zongyi Y, Baifeng L, Funian Z, et al (2017). Risk factors of acute kidney injury after orthotopic liver transplantation in China. Sci Rep, 7:41555.
114. Kamo N, Kaido T, Yagi S, et al (2018). Liver transplantation for intermediate-stage hepatocellular carcinoma. Liver Cancer, 7(2):179-89.
115. Kasahara M, Umeshita K, Sakamoto S, et al (2018). Living donor liver transplantation for biliary atresia: an analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society. Am J Transplant, 18(3):659-68.
116. Lee EC, Kim SH, Shim JR, Park SJ (2018). Small‐for‐size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria. Liver Transpl, 24(1):35-43.
117. Lei M, Yan L-N, Yang J-Y, et al (2018). Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China. World J Gastroenterol, 24(48):5525-5536.
118. Malek-Hosseini SA, Jafarian A, Nikeghbalian S, et al (2018). Liver transplantation status in Iran: a multi-center report on the main transplant indicators and survival rates. Arch Iran Med, 21(7):275-82.
119. Zhong C-P, Xi Z-F, Xia Q (2018). Clinical analysis of liver transplantation in autoimmune liver diseases. Hepatobiliary Pancreat Dis Int, 17(1):27-31.
120. Chen W, Yadav DK, Bai X, et al (2019). Liver transplantation from voluntary organ donor system in China: a comparison between DBD and DCD liver transplants. Gastroenterol Res Pract, 2019:5736702.
121. Baimakhanov Z, Kaniev S, Doskhanov M, et al (2019). Evolution of Liver Transplantation in Kazakhstan: Two-Era Experience of a Single Center, the First Report. Transplant Proc, 51(10):3360-3363.
122. Shen Z, Gu C, Zheng H, et al (2019). A twenty-year review of clinical liver transplantation. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 31(3):269-80.
123. Kurata N, Ogura Y, Ogiso S, et al (2019). Splenectomy in living donor liver transplantation and risk factors of portal vein thrombosis. Hepatobiliary Pancreat Dis Int, 18(4):337-42.
124. Madreseh E, Mahmoudi M, Nassiri-Toosi M, et al (2020). Post Liver Transplantation Survival and Related Prognostic Factors among Adult Recipients in Tehran Liver Transplant Center; 2002–2019. Arch Iran Med, 23(5):326-334.
125. Basiratnia M, Dehghani SM, Razmjoee F, Derakhshan D (2020). Prevalence of Renal Dysfunction Among Pediatric Liver Transplant Recipients. Iran J Kidney Dis, 14(2):119-125.
126. Malek-Hosseini SA, Habibzadeh F, Nikeghbalian S (2019). Shiraz organ transplant center: the largest liver transplant center in the world. Transplantation, 103(8):1523-5.
127. Nikeghbalian S, Malekhosseini SA, Kazemi K, et al (2021). The largest single center report on pediatric liver transplantation: experiences and lessons learned. Ann Surg, 273(2):e70-e72.
128. Roberts MS, Angus DC, Bryce CL, et al (2004). Survival after liver transplantation in the United States: a disease‐specific analysis of the UNOS database. Liver Transpl, 10(7):886-97.
129. Dueland S, Syversveen T, Solheim JM, et al (2020). Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases. Ann Surg, 271(2):212-8.
130. Vogt DP, Henderson JM, Carey WD, Barnes DJS (2002). The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery, 132(4):775-80.
131. Cuervas‐Mons V, Martinez AJ, Dekker A, et al (1986). Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology, 6(3):495-501.
132. Mora NP, Klintmalm GB, Solomon H, et al (1992). Survival after liver transplantation in 300 consecutive patients: the influence of age, clinical status, and pretransplant disease. Transplant Proc, 24(1):156-7.
133. Jain A, Reyes J, Kashyap R, et al (2000). Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg, 232(4):490-500.
134. Smits J, De Meester J, Persijn G, et al (1996). Long-term results of solid organ transplantation. Report from the Eurotransplant International Foundation. Clin Transpl, 109-27.
135. Saidi RF (2012). Current status of liver transplantation. Arch Iran Med, 15(12):772-6.
136. Kadohisa M, Inomata Y, Uto K, et al (2021). Impact of Donor Age on the Outcome of Living-donor Liver Transplantation: Special Consideration to the Feasibility of Using Elderly Donors. Transplantation, 105(2):328-37.
| Files | ||
| Issue | Vol 51 No 10 (2022) | |
| Section | Review Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v51i10.10979 | |
| Keywords | ||
| Liver Transplantation Survival analysis Meta-analysis Asia. | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Ghelichi-Ghojogh M, Rajabi A, Mohammadizadeh F, Shojaie L, Vali M, Afrashteh S, Hassanipour S, Nikbakht H-A, Khezri R, kalteh EA, Fararouei M. Survival Rate of Liver Transplantation in Asia: A Systematic Review and Meta-Analysis. Iran J Public Health. 2022;51(10):2207-2220.
